National Vision - EYE EV/Sales Multiple

Official company branding of nationalvision.com (EYE)

Licensing complexities and in-house laboratories provide National Vision Holdings (EYE) with pricing power. Exclusive contracts with insurance companies serve as the primary defense against online retail, a trend captured by the EV/Sales trajectory on GURU.Markets, where the indicator reaches 951.08. Despite stable demand, a narrow specialization in budget optics leaves the company dependent on the solvency of American consumers.

America's Best Contacts & Eyeglasses (EYE) - Company Value to Revenue from 11/23/2025 to 11/20/2026

America's Best Contacts & Eyeglasses - analytical breakdowns and key metrics (EYE)

- share price and consensus valuation forecast:
- cash balance and cash flow data:
Initial company analysis:EYE (National Vision Holdings)
Flagship merchandise of National Vision Corp

This indicator determines the market value of the business relative to its annual turnover, excluding the impact of leverage to identify the asset's real investment attractiveness. National Vision Holdings (EYE) investments in personnel development and employee retention through educational programs confirm the resilience of the business model, which reflects the company's value-to-revenue trend and testifies to the fundamental strength of its position.

Competitor analysis for National Vision Holdings

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|EV/Sales Multiple Option Care OPCH|Surgery Partners Inc - EV/Sales Multiple|PINC (Premier Corp) - Company Value to Revenue Ratio|PGNY: EV/Sales Multiple|ARDT (Ardent Health Partners) - Enterprise Value-to-Revenue Ratio|SEM (selectmedical.com) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio ASTH|EV/Sales Multiple MD|Enterprise Value-to-Revenue Ratio USPH (US Physical Therapy Inc)|Enterprise Value-to-Revenue Ratio The Pennant Group, Inc. PNTG|Business Value to Revenue ORGO|NUTX - Enterprise Value-to-Revenue Ratio|AUNA - EV/Sales Multiple|SBC Medical Group Inc (SBC) - Enterprise Value-to-Revenue Ratio|EOLS: Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio chs.net|SKIN: Business Value to Revenue|EV/Sales Multiple MDWD|BTMD - Enterprise Value-to-Revenue Multiple|The Joint Chiropractic - Company Value to Revenue|Enterprise Value-to-Revenue Coefficient DCGO (DocGo, Inc)|Total Company Value-to-Revenue Ratio PIII (p3hp.org)|GANX (Gain Therapeutics) - Company Value to Revenue Ratio|euda.com (EUDA) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Basel Medical|CLGN (CollPlant Biotechnologies) - EV/Sales Multiple|EV/Sales Multiple Cuprina Holdings Limited|Enterprise Value-to-Revenue Ratio concordmedical.com (CCM)|Enterprise Value-to-Revenue Ratio AMS (American Shared Hospital)|Enterprise Value-to-Revenue Ratio MEDIROM Corp MRM|EV/Sales Multiple avalon-globocare.com ALBT|DHAI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Longevity Health Holdings XAGE|NIVF (NewGenIvf Group Limited) - Company Value to Revenue|ATI Physical Therapy Inc. - Business Value to Revenue|CMAX (caremax.com) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple